A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart Failure
Status:
Completed
Trial end date:
2024-03-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is assess the effect of danicamtiv, as an inducer on the drug
levels of midazolam in participants with heart failure with reduced ejection fraction
(HFrEF).